3. Wallace ZS, Naden RP, Chari S, Choi HK, Della-Torre E, Dicaire JF, et al. 2020; The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease. Ann Rheum Dis. 79:77–87. DOI:
10.1136/annrheumdis-2019-216561. PMID:
31796497.
Article
4. Deshpande V, Zen Y, Chan JK, Yi EE, Sato Y, Yoshino T, et al. 2012; Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 25:1181–92. DOI:
10.1038/modpathol.2012.72. PMID:
22596100.
Article
5. Levraut M, Cohen M, Bresch S, Giordana C, Burel-Vandenbos F, Mondot L, et al. 2019; Immunoglobulin G4-related hypertrophic pachymeningitis: a case-oriented review. Neurol Neuroimmunol Neuroinflamm. 6:e568. DOI:
10.1212/NXI.0000000000000568. PMID:
31355304. PMCID:
PMC6624094.
Article
6. Dong LL, Sheikh IS, Huang AH, Wu XH, Chen EG, Ying KJ. 2021; Immunoglobulin G4-related disease: case report and literature review. Immunol Res. 69:415–21. DOI:
10.1007/s12026-021-09215-2. PMID:
34374950.
Article
7. Lu LX, Della-Torre E, Stone JH, Clark SW. 2014; IgG4-related hypertrophic pachymeningitis: clinical features, diagnostic criteria, and treatment. JAMA Neurol. 71:785–93. DOI:
10.1001/jamaneurol.2014.243. PMID:
24733677.
8. Berger JR, Snodgrass S, Glaser J, Post MJ, Norenberg M, Benedetto P. 1989; Multifocal fibrosclerosis with hypertrophic intracranial pachymeningitis. Neurology. 39:1345–9. DOI:
10.1212/WNL.39.10.1345. PMID:
2797457.
Article
9. Chan SK, Cheuk W, Chan KT, Chan JK. 2009; IgG4-related sclerosing pachymeningitis: a previously unrecognized form of central nervous system involvement in IgG4-related sclerosing disease. Am J Surg Pathol. 33:1249–52. DOI:
10.1097/PAS.0b013e3181abdfc2. PMID:
19561447.
10. Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, et al. 2001; High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 344:732–8. DOI:
10.1056/NEJM200103083441005. PMID:
11236777.
Article
11. Wallace ZS, Carruthers MN, Khosroshahi A, Carruthers R, Shinagare S, Stemmer-Rachamimov A, et al. 2013; IgG4-related disease and hypertrophic pachymeningitis. Medicine (Baltimore). 92:206–16. DOI:
10.1097/MD.0b013e31829cce35. PMID:
23793110. PMCID:
PMC4553969.
Article
12. Yonekawa T, Murai H, Utsuki S, Matsushita T, Masaki K, Isobe N, et al. 2014; A nationwide survey of hypertrophic pachymeningitis in Japan. J Neurol Neurosurg Psychiatry. 85:732–9. DOI:
10.1136/jnnp-2013-306410. PMID:
24273222.
Article
13. Melenotte C, Seguier J, Ebbo M, Kaphan E, Bernit E, Saillier L, et al. 2019; Clinical presentation, treatment and outcome of IgG4-related pachymeningitis: from a national case registry and literature review. Semin Arthritis Rheum. 49:430–7. DOI:
10.1016/j.semarthrit.2019.05.003. PMID:
31155444.
Article